Beijing Strong Bio expands portfolio with new Digoxin assay kit

Beijing Strong Biotechnologies Co., Ltd. announced it has obtained a medical device registration certificate from the Beijing Municipal Drug Administration. This approval is for a "Digoxin Assay Kit (Chemiluminescent Immunoassay with Magnetic Microparticles)." The registration number for this product is Jing Xie Zhu Zhun 20252400878, and it falls under Registration Category II.

The certificate is valid from its approval date until October 16, 2030. The assay kit is intended for the quantitative determination of digoxin (DIG) content in human serum or plasma for in-vitro use.

The company states that obtaining this certificate enriches its product line in the in-vitro diagnostic chemiluminescence segment. It expects this to enhance its core competitiveness and market expansion capabilities, positively impacting future operations. However, actual sales performance will depend on future market promotion efforts, and the company cannot predict its impact on future financial performance. Investors are cautioned to be aware of investment risks.